Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) EPS (Basic) (2020 - 2025)

LifeStance Health (LFST) has disclosed EPS (Basic) for 6 consecutive years, with $0.04 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 300.0% to $0.04 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.03, a 118.75% increase, with the full-year FY2025 number at $0.03, up 120.0% from a year prior.
  • EPS (Basic) was $0.04 for Q4 2025 at LifeStance Health, up from -$0.01 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.04 in Q4 2025 to a low of -$374.91 in Q3 2021.
  • A 5-year average of -$33.33 and a median of -$0.12 in 2022 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): tumbled 2233751.0% in 2021, then surged 300.0% in 2025.
  • LifeStance Health's EPS (Basic) stood at -$0.32 in 2021, then surged by 59.38% to -$0.13 in 2022, then rose by 7.69% to -$0.12 in 2023, then surged by 83.33% to -$0.02 in 2024, then surged by 300.0% to $0.04 in 2025.
  • Per Business Quant, the three most recent readings for LFST's EPS (Basic) are $0.04 (Q4 2025), -$0.01 (Q2 2025), and -$0.02 (Q4 2024).